Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination

Daryl Geers; Roos S.G. Sablerolles; Debbie van Baarle; Neeltje A. Kootstra; Wim J.R. Rietdijk; Katharina S. Schmitz; Susanne Bogers; Lennert Gommers; Nella J. Nieuwkoop; Laura L.A. van Dijk; Eva van Haren; Melvin Lafeber; Virgil A.S.H. Dalm; Abraham Goorhuis; Douwe F. Postma; Leo G. Visser; Anke L.W. Huckriede; Alessandro Sette; Alba Grifoni; Rik L. de Swart; Marion P.G. Koopmans; P. Hugo M. van der Kuy; Corine H. GeurtsvanKessel; Rory D. de Vries; the SWITCH research group

doi:10.1101/2022.07.15.22277639

Data Availability

All data needed to evaluate the conclusions in the manuscript is present in the main or the supplementary materials. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.